Poor-prognosis Estrogen Receptor-positive Disease : Combining Anti-her-2 and Endocrine Therapy - Medscape News

Anthra, anthracycline; cont, containing; DD, dose dense; doce, docetaxel; ER−, estrogen receptor negative; ER+, estrogen receptor positive; FAC, fluorouracil (5-FU), doxorubicin and cyclophosphamide regimen; FEC, 5-FU, epirubicin and cyclophosphamide ...

Sagent Pharmaceuticals Announces Launch of Irinotecan Hydrochloride Injection in Single Dose Vials - Yahoo Finance

It is indicated in combination with 5-fluorouracil and leucovorin for patients with metastatic carcinoma of the colon or rectum whose disease has recurred or progressed following initial fluorouracil-based therapy. The package insert ...

Genta Reports Results Of Tesetaxel Confirmatory Trial - RTT News

The company said that the 2nd-line study enrolled 53 patients who had progressed on at least one prior chemotherapy regimen that included a platinum compound (cisplatin, oxaliplatin, or carboplatin) and a fluoropyrimidine (5-fluorouracil, capecitabine ...

GI Cancers: Promising Data Across the Board - Medscape News

[6] There will be an Intergroup report looking at the adjuvant chemotherapy comparators of conventional 5-fluorouracil leucovorin vs a much more complex dose-intense regime looking at irinotecan and 5-fluorouracil leucovorin, followed ...

Prodigy Generics and eVenus Announce the Launch of Oncology Injectable Irinotecan. - Genetic Engineering News

It's used in the FOLFIRI chemotherapy regimen consisting of infusional 5-fluorouracil, leucovorin, and irinotecan. Irinotecan is available in 2ML (20 MG per ML) and 5ML (20 MG per ML). "This launch represents an important milestone for Prodigy.

Irinotecan HCl Injection from Sagent - Monthly Prescribing Reference

It is indicated in combination with 5-fluorouracil and leucovorin for patients with metastatic carcinoma of the colon or rectum whose disease has recurred or progressed following initial fluorouracil-based therapy.

Wellstat Grants BTG European Distribution Rights to Investigational Antidote for 5-FU Overexposure - TMCnet

Wellstat Therapeutics Corporation announced today that it has granted Named Patient supply rights and an option to obtain marketing rights in the European Union for the company's investigational drug uridine triacetate to the specialist ...

Genta Announces Results of Tesetaxel Confirmatory Trial in Patients With Advanced Gastric Cancer - NASDAQ

This 2nd-line study enrolled 53 patients who had progressed on at least one prior chemotherapy regimen that included a platinum compound (cisplatin, oxaliplatin, or carboplatin) and a fluoropyrimidine (5-fluorouracil, capecitabine [Xeloda ...

New Colon Cancer Regimen OK with Avastin History - MedPage Today

The latter is the current standard of care, combining leucovorin, fluorouracil, and irinotecan. But there have been questions as to whether aflibercept would be of any use in patients whose disease had previously progressed while on bevacizumab ...

New drug to treat pre-cancerous actinic keratoses - Examiner

Treatment for AK may include surgery, cryosurgery (or freezing), topical creams such as fluorouracil (5-FU), or photodynamic therapy, a type of light therapy can is given over several days.  These treatments destroy the affected area of the epidermis ...